UniSa - IRIS Institutional Research Information System

ALTIERI, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.405
AS - Asia 4.714
EU - Europa 1.729
SA - Sud America 190
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
AN - Antartide 1
Totale 12.098
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.259
HK - Hong Kong 2.812
SG - Singapore 852
CN - Cina 568
UA - Ucraina 399
DE - Germania 395
RU - Federazione Russa 337
VN - Vietnam 216
IT - Italia 184
BR - Brasile 143
CA - Canada 110
FR - Francia 99
IE - Irlanda 96
KR - Corea 96
FI - Finlandia 92
IN - India 42
GB - Regno Unito 30
SE - Svezia 26
MX - Messico 24
TR - Turchia 24
AR - Argentina 18
NL - Olanda 18
BD - Bangladesh 15
JP - Giappone 13
ZA - Sudafrica 13
IQ - Iraq 11
PL - Polonia 11
ES - Italia 10
EU - Europa 10
PK - Pakistan 9
CO - Colombia 8
UZ - Uzbekistan 8
JO - Giordania 6
KE - Kenya 6
PH - Filippine 6
TN - Tunisia 6
VE - Venezuela 6
GR - Grecia 5
ID - Indonesia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
MA - Marocco 4
PY - Paraguay 4
SA - Arabia Saudita 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
RO - Romania 3
BE - Belgio 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
HU - Ungheria 1
IL - Israele 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MQ - Martinica 1
MT - Malta 1
MU - Mauritius 1
NE - Niger 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 12.094
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.807
Ann Arbor 817
Singapore 495
Jacksonville 476
Chandler 406
San Jose 399
Princeton 333
Ashburn 219
Dallas 208
Wilmington 101
Council Bluffs 97
Dublin 96
Ottawa 92
Andover 90
Lauterbourg 88
Nanjing 86
Nürnberg 86
Beijing 79
Boardman 76
Dong Ket 76
Woodbridge 76
The Dalles 74
Ho Chi Minh City 54
Pellezzano 54
Houston 40
Fairfield 39
Jinan 36
Changsha 35
Shenyang 35
Munich 34
Hanoi 28
Hebei 24
Jiaxing 24
Los Angeles 24
Tianjin 24
São Paulo 22
Nanchang 20
Naples 20
New York 20
Pune 17
Zhengzhou 17
Brooklyn 16
Seattle 16
Norwalk 15
San Francisco 15
Orem 14
Salerno 14
Moscow 13
Redwood City 13
Izmir 11
Mexico City 11
Atlanta 10
Chicago 10
Guangzhou 10
Johannesburg 10
Santa Clara 10
Columbus 9
Hangzhou 9
Nuremberg 9
San Diego 9
Vietri Sul Mare 9
Warsaw 9
Amsterdam 8
Boston 8
Cambridge 8
Da Nang 8
Düsseldorf 8
Montreal 8
Phoenix 8
Tashkent 8
Tokyo 8
Baghdad 7
Chennai 7
Frankfurt am Main 7
Haiphong 7
Ningbo 7
Stockholm 7
Turku 7
Amman 6
Hải Dương 6
Mountain View 6
Taiyuan 6
Taizhou 6
London 5
Mestre 5
Rio de Janeiro 5
Toronto 5
Baiano 4
Charlotte 4
City of London 4
Denver 4
Edinburgh 4
Fort Worth 4
Goiânia 4
Guardia Sanframondi 4
Helsinki 4
Lappeenranta 4
Madrid 4
Manchester 4
Paris 4
Totale 8.309
Salva come PNG Salva come JPEG
Nome #
Modulation of BAG3 expression in human normal urothelial cells by Diuron 1.058
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: Prognostic indicators of disease-specific survival 883
Amelanotic Malignant Melanoma of the Male Urethra: A Potential Diagnostic Pitfall 530
Ultrasonographic evaluation of urethrovesical junction mobility: correlation with type of delivery and stress urinary incontinence 415
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 363
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 360
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol 353
A preoperative clinical prognostic model for non-metastatic renal cell carcinoma 243
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma 229
Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study 173
Choroidal evaluation in patients under alpha-lytic therapy 142
A randomised study evaluating maintenance schedule in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer 138
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer 132
A serum metabolomic signature for the detection and grading of bladder cancer 132
The best prostate biopsy sampling system—fusion and systematic biopsy: A single center experience 125
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 125
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 124
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. 122
Can pT2 classification for renal cell carcinoma be improved? An international multicenter experience? 118
Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report 117
Proposal for revision of the TNM classification system for renal cell carcinoma 116
Role of Polysomy 17 in Transitional Cell Carcinoma of the Bladder: Immunohistochemical Study of HER2/neu Expression and FISH Analysis of c-erbB-2 Gene and Chromosome 17 115
A randomized trial comparing tamoxifen therapy vs. Tamoxifen prophylaxis in bicalutamide-induced gynecomastia 115
Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens 114
Prognostic relevance of tumour size in T3a renal cell carcinoma: A multicentre experience 114
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas 113
Altered expression of specific genes in the HOX network is associated with human bladder transitional cell carcinomas 109
KPNA2/ERG Coexpression is Associated with Early Recurrence in Advanced Prostate Cancers 108
["Classic" vs autolubricant catheterization for endovesicular chemotherapy. Preliminary experience]. 107
Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study 106
A nomogram predicting renal cell carcinoma-specific survival in patients with nodal metastases is more accurate than any individual variable 105
PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer Cells 102
Evaluation of expression of chromatin assembly factor-1 (CAF-1) p60 in prostatic preneoplastic lesions 101
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma 100
[Erectile dysfunction in kidney transplanted patients]. 98
[The Rokitansky-Kuster-Hauser syndrome with chromosome XO/XX mosaicism (single pelvic kidney)]. 98
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer 95
[Imaging diagnosis of non-lymph node metastasis of bladder carcinoma]. 95
Prostate Health Index (phi) Is Able To Discriminate Benign and Precancerous Conditions From Prostate Cancer 93
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility 92
Frequency, clinical presentation and evolution of renal oncocytomas: Multicentric experience from a European database 92
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 92
Zoledronic Acid Increases the Expression of Ndrg1 Gene In Human Androgen-independent Prostate Cancer Pc3 Cells 91
Phase II marker lesion study of 6-week intravesical gemcitabine instillation in patients with low risk non muscle invasive bladder tumours 91
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 91
CAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers 91
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy - A multicenter European study 90
Prognostic significance of T3A renal cell carcinoma with adrenal gland involvement: An international multicenter experience 90
Endovesical Gemcitabine In Recurrent Previously Treated Non-muscle-invasive Bladder Cancer 89
Docetaxel Retreatment In Docetaxel-pretreated Castration-resistant Prostate Cancer 89
Significance of tumor size in locally advanced renal cell carcinoma (pT3a): An international multicenter experience 89
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 89
Gynecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options 89
Cigarette Smoking and Drinking Water Source: Correlation with Clinical Features and Pathology of Superficial Bladder Carcinoma 87
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 86
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 86
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells 86
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer: Update 2016 85
Effects of the Erbb1/erbb2 Kinase Inhibitor Gw2974 On the Growth and Nse, Chromogranin A and Osteopontin Content of the Androgen-independent Prostate Cancer Cell Line Pc-3 84
Contemporary Management of Non-muscle Invasive Bladder Cancer At Italian Referral Centres Adopting Eau Guidelines 82
Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas 82
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 80
Efficacy of one-year maintenance in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer. Results at 24 months of a randomized trial 80
Pca3 Comparison With Prostate Health Index (phi) In Repeat Biopsy Patients 80
Matrix Metalloproteinase-2 And-9 In the Urine of Prostate Cancer Patients 79
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital 79
Effects of the antidepressant St. John's wort (hypericum perforatum) on rat and human vas deferens contractility 79
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 78
Uracyst Enhances the Antitumor Activity of Drugs In Bladder Cancer Cells 78
Not traditional prognostic factors in human conventional renal carcinoma. 78
Npc - A Newer Revolutionary Test For Evaluation of Clinical Series. Bladder Cancer 77
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 77
Distribution of smoking, water resource and other environmental factors in patients affected by superficial bladder cancer 75
Out-patient low-dose oral chemotherapy in hormone refractory prostate carcinoma (HRPC) patients unfit for hospital admittance 74
Presence of systemic symptoms is the foremost predictor of mortality in patients with exclusive nodal metastases 74
Drinking water source and cigarette smoking in transitional cell carcinoma of the bladder 73
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience 72
Low-dose oral chemotherapy for hormone refractory prostate carcinoma (HRPC). Estramustine phosphate versus estramustine phosphate and etoposide. A randomised phase II study of GSTU Foundation 71
Docetaxel and Carboplatin In Docetaxel Pretreated Castraction-resistant Prostate Cancer: Preliminary Results 71
Smoking Status, Recurrence Risk and Intravesical Chemotherapy In Non-muscle-invasive Bladder Cancer 70
Predictive accuracy of four prognostic models for non-metastatic renal cell carcinoma after nephrectomy: A comparative study. 70
Standard versus hydrophilic catheterization in the adjuvant treatment of patients with superficial bladder cancer 70
Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: A retrospective study 70
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content 69
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder - A study from Gruppo Studi Tumori Urologici (GSTU) Foundation 69
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 68
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 68
Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis 68
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis 66
Local hyperthermia for treatment of advanced prostatic carcinoma: preliminary results. 62
Urotensin Ii Receptor Is Involved In the Regulation of Motility of Prostate Adenocarcinoma Cells and Predicts the Clinical Outcome of Prostate Cancer Patients 61
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 58
Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? 54
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) 48
Totale 12.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.367
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 0 0 0 0 8 89 86
2021/2022566 2 0 1 6 7 8 12 30 94 86 68 252
2022/2023975 95 55 16 114 137 231 0 101 139 0 65 22
2023/2024343 44 68 16 20 30 32 8 36 1 3 8 77
2024/2025783 23 6 20 27 16 183 108 90 90 26 81 113
2025/20265.273 1.393 1.174 727 111 371 163 648 135 249 302 0 0
Totale 12.175